Mandal, R
As stress and fatigue are key inhibitors of regular physical activity, Phosphatidylserine helps the body recover faster, enabling individuals to engage in more consistent exercise routines, which is essential for weight loss
developed by Eli Lilly and Company, retatrutide has shown exceptional results in clinical research, with phase 2 trials demonstrating average weight loss of up to 24% over 48 weeks alongside improvements in insulin sensitivity, blood glucose regulation, lipid profiles, and reductions in visceral fat and liver fat, positioning it as one of the most promising next-generation obesity treatments currently under study
Can GLP-1 Medications Reduce Breast Cancer Risk
Key Takeaway: Empowering your body with the right tools allows you to manage genetic traits with confidence
In January 2023, Nicaises doctor suggested he consider taking an anti-obesity medication because he was on the brink of needing a fourth blood pressure medication